• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 3D CT 的高剂量率近距离放疗宫颈癌:对晚期直肠出血和局部控制的临床影响。

3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control.

机构信息

Research Institute and Hospital, National Cancer Center, Republic of Korea.

出版信息

Radiother Oncol. 2010 Dec;97(3):507-13. doi: 10.1016/j.radonc.2010.10.002. Epub 2010 Nov 11.

DOI:10.1016/j.radonc.2010.10.002
PMID:21074881
Abstract

BACKGROUND AND PURPOSE

To identify the impact of 3D CT-based high-dose-rate intracavitary radiotherapy (ICR) on late rectal bleeding (LRB) and local control (LC) in patients with cervical cancer.

MATERIAL AND METHODS

The outcomes of 97 consecutive patients treated with 3D CT-based ICR (3D-ICR) were compared with those of 133 consecutive historical patients with conventional 2D brachytherapy planning (2D-ICR). The median follow-up periods were 41 and 56 months for the 3D and 2D groups, respectively.

RESULTS

The overall rectal bleeding rate was similar between the groups (42% for 3D-ICR vs. 44% for 2D-ICR); however, the incidence of severe LRB was higher in the 2D-ICR group than in the 3D-ICR group (13% vs. 2%, respectively; p=0.02). In multivariate analysis, the factors associated with severe LRB were tumor >4 cm (12% vs. 3%) and 2D-ICR (10% vs. 2%). The LC rates were 97% and 91% for 3D-ICR and 2D-ICR, respectively (p=0.14); the progression-free survival rate was 80% for both groups. A significant difference in the LC rates between the two groups was observed in patients with larger tumor sizes with the tumor diameter of over 4 cm (98% vs. 81% by 3D-ICR vs. 2D-ICR, respectively; p=0.02).

CONCLUSIONS

The implementation of 3D-ICR in radiotherapy for cervical cancer can reduce the incidence of severe LRB and may improve the LC rate.

摘要

背景与目的

旨在确定基于 3D CT 的高剂量率腔内放疗(ICR)对宫颈癌患者晚期直肠出血(LRB)和局部控制(LC)的影响。

材料与方法

比较了 97 例连续接受基于 3D CT 的 ICR(3D-ICR)治疗的患者的结果与 133 例连续接受传统 2D 近距离治疗计划(2D-ICR)的历史患者的结果。3D 和 2D 组的中位随访时间分别为 41 个月和 56 个月。

结果

两组的总体直肠出血率相似(3D-ICR 为 42%,2D-ICR 为 44%);然而,2D-ICR 组严重 LRB 的发生率高于 3D-ICR 组(分别为 13%和 2%;p=0.02)。多因素分析显示,严重 LRB 的相关因素是肿瘤>4cm(12%比 3%)和 2D-ICR(10%比 2%)。3D-ICR 和 2D-ICR 的 LC 率分别为 97%和 91%(p=0.14);两组的无进展生存率均为 80%。在肿瘤直径大于 4cm 的患者中,两组的 LC 率存在显著差异(3D-ICR 为 98%,2D-ICR 为 81%,分别为 3D-ICR 比 2D-ICR;p=0.02)。

结论

宫颈癌放疗中实施 3D-ICR 可降低严重 LRB 的发生率,并可能提高 LC 率。

相似文献

1
3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control.基于 3D CT 的高剂量率近距离放疗宫颈癌:对晚期直肠出血和局部控制的临床影响。
Radiother Oncol. 2010 Dec;97(3):507-13. doi: 10.1016/j.radonc.2010.10.002. Epub 2010 Nov 11.
2
CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.基于 CT 的宫颈癌高剂量率腔内近距离治疗后直肠 3D 剂量-体积参数与晚期直肠并发症
J Radiat Res. 2010;51(2):215-21. doi: 10.1269/jrr.09118.
3
Comparison between in vivo dosimetry and barium contrast technique for prediction of rectal complications in high-dose-rate intracavitary radiotherapy in cervix cancer patients.宫颈癌患者高剂量率腔内放疗中体内剂量测定与钡剂造影技术在预测直肠并发症方面的比较。
Strahlenther Onkol. 2003 Mar;179(3):191-6. doi: 10.1007/s00066-003-1015-2.
4
High dose rate brachytherapy for carcinoma of the cervix: risk factors for late rectal complications.子宫颈癌高剂量率近距离放射治疗:直肠晚期并发症的危险因素
Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):615-21. doi: 10.1016/s0360-3016(97)00849-3.
5
Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.宫颈癌患者高剂量率腔内放疗后直肠并发症与直肠剂量的相关性分析:体内剂量学分析
Radiat Med. 1999 Jul-Aug;17(4):289-93.
6
Who Really Benefits from 3D-Based Planning of Brachytherapy for Cervical Cancer?谁真正受益于宫颈癌近距离治疗的 3D 计划?
J Korean Med Sci. 2018 Apr 13;33(18):e135. doi: 10.3346/jkms.2018.33.e135. eCollection 2018 Apr 30.
7
Rectal dose and source strength of the high-dose-rate iridium-192 both affect late rectal bleeding after intracavitary radiation therapy for uterine cervical carcinoma.高剂量率铱-192 腔内放疗后晚期直肠出血与直肠剂量和源强均有关。
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):758-64. doi: 10.1016/j.ijrobp.2009.05.030. Epub 2009 Oct 14.
8
Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.调强放疗联合近距离放疗治疗前列腺癌时,其副作用比三维适形放疗少。
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):630-5. doi: 10.1016/j.ijrobp.2011.06.2013. Epub 2011 Nov 16.
9
CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.CT引导下宫颈癌腔内放疗:基于剂量体积参数的传统A点计划与基于临床靶区的三维计划的比较。
Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):197-204. doi: 10.1016/j.ijrobp.2005.06.015. Epub 2005 Sep 19.
10
Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.基于线性二次模型的两种高剂量率腔内近距离放射治疗宫颈癌等效应分割方案的临床比较
Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):179-89. doi: 10.1016/j.ijrobp.2003.10.025.

引用本文的文献

1
A Systematic Review of SBRT Boost for Cervical Cancer Patients Who Cannot Benefit from Brachytherapy.对于无法从近距离放疗中获益的宫颈癌患者,立体定向体部放疗强化治疗的系统评价
Curr Oncol. 2025 Mar 15;32(3):170. doi: 10.3390/curroncol32030170.
2
The Clinical Course of the Late Toxicity of Definitive Radiotherapy in Cervical Cancer.宫颈癌根治性放疗晚期毒性的临床病程。
Medicina (Kaunas). 2024 Aug 21;60(8):1364. doi: 10.3390/medicina60081364.
3
Dosimetric comparison of rectal dose-reductive techniques in intra-cavitary brachytherapy for cervical cancer: A retrospective analysis.
宫颈癌腔内近距离放疗中直肠剂量降低技术的剂量学比较:一项回顾性分析。
J Contemp Brachytherapy. 2023 Aug;15(4):269-274. doi: 10.5114/jcb.2023.130842. Epub 2023 Aug 30.
4
Feature Importance Analysis of a Deep Learning Model for Predicting Late Bladder Toxicity Occurrence in Uterine Cervical Cancer Patients.用于预测子宫颈癌患者晚期膀胱毒性发生的深度学习模型的特征重要性分析
Cancers (Basel). 2023 Jul 2;15(13):3463. doi: 10.3390/cancers15133463.
5
Safety and Efficacy of 2D Brachytherapy vs. 3D Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer-A Single Institution Retrospective Study.2D 近距离放疗与 3D 图像引导自适应近距离放疗治疗局部晚期宫颈癌的安全性和疗效:单中心回顾性研究。
Curr Oncol. 2023 May 13;30(5):4966-4978. doi: 10.3390/curroncol30050375.
6
Application of three-dimensional multi-imaging combination in brachytherapy of cervical cancer.三维多影像联合在宫颈癌近距离治疗中的应用
Radiol Med. 2023 May;128(5):588-600. doi: 10.1007/s11547-023-01632-7. Epub 2023 May 3.
7
Long-Term Efficacy and Toxicity of Intensity-Modulated Radiotherapy in Bulky Cervical Cancer.大体积宫颈癌调强放疗的长期疗效和毒性
Int J Environ Res Public Health. 2023 Jan 9;20(2):1161. doi: 10.3390/ijerph20021161.
8
Prediction models for brachytherapy-induced rectal toxicity in patients with locally advanced pelvic cancers: a systematic review.局部晚期盆腔癌患者近距离放疗所致直肠毒性的预测模型:一项系统评价
J Contemp Brachytherapy. 2022 Aug;14(4):411-422. doi: 10.5114/jcb.2022.119427. Epub 2022 Aug 31.
9
Point-A vs. volume-based brachytherapy for the treatment of cervix cancer: A meta-analysis.点剂量与基于体积的近距离放疗治疗宫颈癌的比较:一项荟萃分析。
Radiother Oncol. 2022 May;170:70-78. doi: 10.1016/j.radonc.2022.02.038. Epub 2022 Mar 5.
10
High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.高剂量率近距离放疗用于局部晚期宫颈癌的加强治疗:4种分割方案的肿瘤学结局及毒性分析
Clin Transl Radiat Oncol. 2021 Nov 6;32:15-23. doi: 10.1016/j.ctro.2021.10.005. eCollection 2022 Jan.